Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Parker

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Bone and Joint Surgery. American Volume|September 1, 1985
Total condylar knee replacement. A study of factors influencing range of motion as late as two years after arthroplastyD J Schurman, J N Parker, D Ornstein
Herpes : the Journal of the IHMF|February 28, 2002
Genetically engineered human herpes simplex virus in the treatment of brain tumoursJ M Markert, J N Parker, G Y Gillespie, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1997
Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytesJ N Parker, W Zhao, K J Askins, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 31, 2000
Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entryW M Chien, J N Parker, D C Schmidt-Grimminger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2000
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumorsJ N Parker, G Y Gillespie, C E Love, et al.
Cancer Gene Therapy|September 23, 2006
Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumorsM B Guffey, J N Parker, W S Luckett, et al.
Gene Therapy|April 13, 2007
Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic virusesA C Shah, J N Parker, G Y Gillespie, et al.
Surgery|August 30, 2003
Surgical complications exert a lasting effect on disease-specific health-related quality of life for patients with colorectal cancerThomas Anthony, Joshua Long, Linda S Hynan, et al.
Journal of Virology|January 7, 1998
Viral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytesR D Steenbergen, J N Parker, S Isern, et al.
Oncogene|September 19, 1996
Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18qR D Steenbergen, J M Walboomers, C J Meijer, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Bone and Joint Surgery. American Volume|September 1, 1985
Total condylar knee replacement. A study of factors influencing range of motion as late as two years after arthroplastyD J Schurman, J N Parker, D Ornstein
Herpes : the Journal of the IHMF|February 28, 2002
Genetically engineered human herpes simplex virus in the treatment of brain tumoursJ M Markert, J N Parker, G Y Gillespie, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1997
Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytesJ N Parker, W Zhao, K J Askins, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|August 31, 2000
Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entryW M Chien, J N Parker, D C Schmidt-Grimminger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2000
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumorsJ N Parker, G Y Gillespie, C E Love, et al.
Cancer Gene Therapy|September 23, 2006
Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumorsM B Guffey, J N Parker, W S Luckett, et al.
Gene Therapy|April 13, 2007
Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic virusesA C Shah, J N Parker, G Y Gillespie, et al.
Surgery|August 30, 2003
Surgical complications exert a lasting effect on disease-specific health-related quality of life for patients with colorectal cancerThomas Anthony, Joshua Long, Linda S Hynan, et al.
Journal of Virology|January 7, 1998
Viral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytesR D Steenbergen, J N Parker, S Isern, et al.
Oncogene|September 19, 1996
Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18qR D Steenbergen, J M Walboomers, C J Meijer, et al.
Pageof 1